Analysis of Nuclear Receptor Coactivator 5 (NCOA5) Messenger RNA Expression and rs2903908 Single Nucleotide Polymorphism of NCOA5 in an Egyptian Cohort with Behçet’s Disease: A Single-Center Case-control Study

Autor:	Basma M Medhat, Noha M. Abdel Baki, Dina M. Rasheed Bahgat, Fatema T. Elgengehy, Dina Koptan, Riham S. H. M. Allam, Asmaa A. Abdelrasool
Rok vydání:	2021
Předmět:	medicine.medical_specialty Messenger RNA business.industry Case-control study Single-nucleotide polymorphism Ophthalmology Endocrinology Real-time polymerase chain reaction Nuclear receptor Internal medicine Genotype Coactivator Immunology and Allergy Medicine NCOA5 business
Zdroj:	Ocular Immunology and Inflammation. 30:1436-1446
ISSN:	1744-5078 0927-3948
DOI:	10.1080/09273948.2021.1889610
Popis:	The nuclear receptor coactivator 5 (NCOA5) has been linked to several inflammatory disorders, including Behcet's disease (BD). We evaluated the expression of NCOA5 messenger RNA (mRNA) using real-time reverse transcription-polymerase chain reaction, and analyzed the rs2903908 T > C of NCOA5 using TaqMan allelic discrimination assay in 49 Egyptian BD patients and 50 controls. The NCOA5 mRNA levels were higher in patients compared to controls (p = .02), female patients compared to males (p = .037), and in patients with ocular involvement (p = .049). Non-CC genotype carriers had a higher frequency of articular manifestations compared with CC carriers (p = .047). Genotypes CC + CT were associated with reduced risk of cutaneous involvement (OR = 0.27, p = .04). CC carriers with active BD or cutaneous manifestations displayed significantly lower NCOA5 mRNA expression than TT carriers. Our results demonstrate that NCOA5 is linked to BD clinical findings and activity.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6269983e55cb81c558654d7a55f86b6e https://doi.org/10.1080/09273948.2021.1889610 Zobrazit plný text záznamu